Logo image of RESN

RESONANT INC (RESN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:RESN - Common Stock

4.48
-0.01 (-0.22%)
Last: 3/25/2022, 8:14:03 PM
4.48
0 (0%)
After Hours: 3/25/2022, 8:14:03 PM
Fundamental Rating

2

RESN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 48 industry peers in the Communications Equipment industry. RESN has a bad profitability rating. Also its financial health evaluation is rather negative. RESN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RESN had negative earnings in the past year.
RESN Yearly Net Income VS EBIT VS OCF VS FCFRESN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA -126.82%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RESN Yearly ROA, ROE, ROICRESN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -100 -200 -300

1.3 Margins

The Operating Margin and Gross Margin are not available for RESN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) -1649.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RESN Yearly Profit, Operating, Gross MarginsRESN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 -1K -2K -3K -4K -5K

More info and screens

3

2. Health

2.1 Basic Checks

RESN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, RESN has an improved debt to assets ratio.
RESN Yearly Shares OutstandingRESN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M
RESN Yearly Total Debt VS Total AssetsRESN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that RESN is in the distress zone and has some risk of bankruptcy.
RESN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACCN/A
RESN Yearly LT Debt VS Equity VS FCFRESN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M 20M -20M

2.3 Liquidity

RESN has a Current Ratio of 3.13. This indicates that RESN is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 3.13 indicates that RESN has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
RESN Yearly Current Assets VS Current LiabilitesRESN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for RESN have decreased by -1.45% in the last year.
The Revenue for RESN has decreased by -31.01% in the past year. This is quite bad
The Revenue has been growing by 48.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.68%
Revenue 1Y (TTM)-31.01%
Revenue growth 3Y61.2%
Revenue growth 5Y48.66%
Sales Q2Q%-12.95%

3.2 Future

The Earnings Per Share is expected to grow by 1.36% on average over the next years.
Based on estimates for the next years, RESN will show a very strong growth in Revenue. The Revenue will grow by 110.03% on average per year.
EPS Next Y24.88%
EPS Next 2Y7.44%
EPS Next 3Y0.95%
EPS Next 5Y1.36%
Revenue Next Year265.95%
Revenue Next 2Y189.1%
Revenue Next 3Y169.02%
Revenue Next 5Y110.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RESN Yearly Revenue VS EstimatesRESN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RESN Yearly EPS VS EstimatesRESN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RESN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RESN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RESN Price Earnings VS Forward Price EarningsRESN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -8.14
RESN Per share dataRESN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.44%
EPS Next 3Y0.95%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RESN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RESONANT INC

NASDAQ:RESN (3/25/2022, 8:14:03 PM)

After market: 4.48 0 (0%)

4.48

-0.01 (-0.22%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)03-22 2022-03-22/bmo
Earnings (Next)04-26 2022-04-26
Inst Owners0%
Inst Owner Change0%
Ins Owners2.86%
Ins Owner Change0%
Market Cap301.01M
Revenue(TTM)2.18M
Net Income(TTM)-35.97M
Analysts74.55
Price Target4.59 (2.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 138.08
P/FCF N/A
P/OCF N/A
P/B 19.73
P/tB N/A
EV/EBITDA -8.14
EPS(TTM)-0.57
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.03
BVpS0.23
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -126.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -1649.86%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 1.08
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.68%
EPS Next Y24.88%
EPS Next 2Y7.44%
EPS Next 3Y0.95%
EPS Next 5Y1.36%
Revenue 1Y (TTM)-31.01%
Revenue growth 3Y61.2%
Revenue growth 5Y48.66%
Sales Q2Q%-12.95%
Revenue Next Year265.95%
Revenue Next 2Y189.1%
Revenue Next 3Y169.02%
Revenue Next 5Y110.03%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

RESONANT INC / RESN FAQ

What is the fundamental rating for RESN stock?

ChartMill assigns a fundamental rating of 2 / 10 to RESN.


What is the valuation status for RESN stock?

ChartMill assigns a valuation rating of 0 / 10 to RESONANT INC (RESN). This can be considered as Overvalued.


How profitable is RESONANT INC (RESN) stock?

RESONANT INC (RESN) has a profitability rating of 0 / 10.


Can you provide the financial health for RESN stock?

The financial health rating of RESONANT INC (RESN) is 4 / 10.